对CFTR无意义突变的治疗方法
Mairead Kelly-Aubert1, Kari Thrasher2, Andrei A Korostelev3
1Université de Paris, CNRS, INSERM, Institut Necker-Enfants Malades, Paris, France.
概括
研究人员正在探索三种创新策略,以克服CFTR基因的无意义突变,旨在恢复功能性蛋白质生产,用于治疗囊性纤维化等遗传疾病.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 在CFTR基因中无意义的突变导致过早终止子 (PTCs),导致截断,非功能性蛋白质和通过无意义中介衰变 (NMD) 的转录降解.
- 读透策略旨在通过促进在PTC中氨基酸的纳入来实现全长功能蛋白质的合成.
研究的目的:
- 审查阅读策略的最新进展,以抑制CFTR基因的无意义突变.
- 要突出三个有前途的治疗方法:小分子化合物,抑制器tRNA和读透诱导的反感性寡核酸 (R-ASOs).
主要方法:
- 高通量选用于识别具有减少目标外影响的新型小分子化合物.
- 为设计解码PTCs的外源抑制器tRNA开发和传递策略.
- 设计针对PTC下游的互补区域的R-ASO,以诱导阅读.
主要成果:
- 新型小分子化合物,包括氨基糖化物衍生物,显示出潜力,具有较少的非目标效应.
- 抑制器tRNA及其传递系统正在积极研究高读透效率.
- 在临床前研究中,R-ASOs证明了对引起疾病的CFTRmRNAs的读透的可行性.
结论:
- 三个审查的阅读策略显示了治疗CFTR无意义突变的临床前可行性.
- 进一步优化输送,药理动力学和最小化非目标效应对于人类翻译至关重要.
- 未来的研究应该解决在正常停止密码子上的潜在读透,以确保安全.
更多相关视频
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
11.2K
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
20.2K
相关概念视频
01:24Cystic Fibrosis: Management
593
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
593
01:23Cystic Fibrosis: Pathogenesis
960
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
960
02:27Nonsense-mediated mRNA Decay
12.0K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
12.0K
01:39Mutations
95.2K
Overview
95.2K
01:29Pharmacogenomics: Identification of New Drug Targets
55
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
55